The BODs of AVX could keep saying that since they are still get paid well.
If AVX could not convice the PGL shareholders with the great DCF (discount cash flow) or NPV (net present value) of its ATC Project, how could they possibly convince the big pharma?
Don't you understand the best time to get the maximum value for ATC had gone since AVX is runing out of cash and can not complete its phase III trials without extra cah, such as PGL's. ATC will be only a second-line HIV-drug and only the big pharma which has already the first-line ones would interest. They could afford to wait until the results of 24-w completed with the positive and then they would start to consider AVX's. And AVX would be already dead if they are not going to get PGL's cash.
AVX Price at posting:
6.8¢ Sentiment: None Disclosure: Not Held
